🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Jana L. Dawson

Moffitt Cancer Center

ORCID: 0000-0002-4901-0897
MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Melphalan and Exportin 1 Inhibitors Exert Synergistic Antitumor Effects in Preclinical Models of Human Multiple Myeloma”.

Melphalan and Exportin 1 Inhibitors Exert Synergistic Antitumor Effects in Preclinical Models of Human Multiple Myeloma

Cancer Research(2020)10.1158/0008-5472.can-19-0677
N/A
0.913DataRank · unranked
21 citations

Yan Cui, Alexis A. Bauer, Jana L. Dawson, Juan Arias Gómez, Jongphil Kim +5 more

Data from Melphalan and Exportin 1 Inhibitors Exert Synergistic Antitumor Effects in Preclinical Models of Human Multiple Myeloma

(2023)10.1158/0008-5472.c.6511792.v1
N/A
0DataRank · unranked
0 citations

Yan Cui, Alexis A. Bauer, Jana L. Dawson, Juan A. Gomez, Jongphil Kim +5 more

Data from Potentiation of a Topoisomerase I Inhibitor, Karenitecin, by the Histone Deacetylase Inhibitor Valproic Acid in Melanoma: Translational and Phase I/II Clinical Trial

(2023)10.1158/1078-0432.c.6517464
N/A
0DataRank · unranked
0 citations

Jana L. Dawson, Ronald C. DeConti, Elona Biçaku, Douglas C. Marchion, Sem Bastien +6 more

Data from Potentiation of a Topoisomerase I Inhibitor, Karenitecin, by the Histone Deacetylase Inhibitor Valproic Acid in Melanoma: Translational and Phase I/II Clinical Trial

(2023)10.1158/1078-0432.c.6517464.v1
N/A
0DataRank · unranked
0 citations

Jana L. Dawson, Ronald C. DeConti, Elona Biçaku, Douglas C. Marchion, Sem Bastien +6 more